PRODUCT CLASSIFICATION
GHRH Analogue
ACNE RISK
None
WATER RETENTION
Absent
HBR
Not Present
HEPATOTOXICITY
Non-existent
AROMATIZATION
No
MANUFACTURER
Beligas
WAREHOUSE
International Warehouse 3
ACTIVE SUBSTANCE
GHRH Peptide
Introducing CJC-1295, a powerful synthetic analogue of growth hormone-releasing hormone (GHRH) composed of 30 amino acids. This cutting-edge peptide is celebrated for its remarkable ability to elevate growth hormone and IGF-1 levels while preserving the natural rhythm of GH secretion.
Often combined with Ipamorelin, CJC-1295 harnesses the unique benefits of GHRH without the common side effects associated with other peptides. Unlike its counterparts, Ipamorelin promotes growth hormone release without triggering appetite changes or increasing cortisol, acetylcholine, prolactin, or aldosterone levels. Enjoy the well-tolerated synergy of CJC-1295 and Ipamorelin for optimal results.
Target Gland: Pituitary
Key Advantages of CJC-1295:- Boosts growth hormone and IGF-1 secretion without elevating prolactin levels
- Supports increased body weight and length through enhanced protein synthesis
- Promotes muscle growth and improved bone density
- Strengthens immune function for better overall health
- Enhances cognitive function and memory retention
- Boosts collagen production for healthier skin
- Facilitates fat loss and supports cellular repair and regeneration
CJC-1295 also promotes deep slow-wave sleep, essential for muscle growth, memory consolidation, and overall rejuvenation.
Understanding CJC-1295 Types:
GHRH is naturally produced in the hypothalamus and its pulsatile release stimulates growth hormone secretion from the pituitary gland. However, GHRH has a fleeting half-life of just a few minutes, necessitating rapid clearance from the bloodstream.
The active segment of GHRH comprises the first 29 amino acids and is available as the peptide Sermorelin, which has been optimized to extend its half-life to around 30 minutes, giving rise to CJC-1295. Further enhancement with DAC (Drug Affinity Complex) allows it to attach to albumin, prolonging its half-life to approximately 8 days, resulting in CJC-1295 + DAC. For those seeking to mimic natural GH spikes at night, CJC-1295 is also available without DAC.
This prolonged half-life means injections are required only once or twice weekly, but the consistent blood levels provide a steady stimulus for GH release from the pituitary via the GHRH receptor. Note that this approach may reduce the amplitude of GH pulses, potentially leading to diminished GH tissue stimulation over time.
Safety Considerations:
For users of long-acting CJC compounds, it is recommended to take "hormone holidays" every three to six months for about three months to allow the pituitary gland to recover. During these breaks, Sermorelin can replace CJC-1295 + DAC. This practice may help prevent the development of GH resistance, although these are theoretical concerns, as extensive long-term studies are still lacking.
Possible side effects of CJC-1295 may include mild reactions at the injection site (such as irritation, swelling, and pain), as well as headaches, flushing, transient low blood pressure, nausea, and abdominal discomfort.